[go: up one dir, main page]

AU1392000A - Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses - Google Patents

Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses

Info

Publication number
AU1392000A
AU1392000A AU13920/00A AU1392000A AU1392000A AU 1392000 A AU1392000 A AU 1392000A AU 13920/00 A AU13920/00 A AU 13920/00A AU 1392000 A AU1392000 A AU 1392000A AU 1392000 A AU1392000 A AU 1392000A
Authority
AU
Australia
Prior art keywords
water
dry
avoiding
maillard reaction
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13920/00A
Inventor
Olivier Broussaud
Guy Derrieu
Jean-Luc Pougnas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virbac Corp
Original Assignee
Virbac SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac SA filed Critical Virbac SA
Publication of AU1392000A publication Critical patent/AU1392000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Freezing, Cooling And Drying Of Foods (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)

Abstract

The invention concerns dry compositions avoiding Maillard reaction in dry state and soluble in the presence of water, characterised in that they contain in combination: at least a molecule (A) comprising one or several amino groups protected by protector groups, said protector groups being eliminated in the presence of water and at least a molecule (B) bearing one or several carbonyl groups.
AU13920/00A 1998-12-01 1999-11-30 Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses Abandoned AU1392000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9815113A FR2786395A1 (en) 1998-12-01 1998-12-01 DRY COMPOSITIONS SOLUBLE IN THE PRESENCE OF WATER AND AVOIDING THE MESH REACTION IN THE DRY CONDITION, THEIR PREPARATION AND THEIR APPLICATIONS
FR9815113 1998-12-01
PCT/FR1999/002955 WO2000032170A1 (en) 1998-12-01 1999-11-30 Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses

Publications (1)

Publication Number Publication Date
AU1392000A true AU1392000A (en) 2000-06-19

Family

ID=9533406

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13920/00A Abandoned AU1392000A (en) 1998-12-01 1999-11-30 Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses

Country Status (8)

Country Link
EP (1) EP1135110B1 (en)
JP (1) JP2002531392A (en)
KR (1) KR20010093797A (en)
AT (1) ATE247459T1 (en)
AU (1) AU1392000A (en)
DE (1) DE69910610T2 (en)
FR (1) FR2786395A1 (en)
WO (1) WO2000032170A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
GB2404336A (en) * 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
CA2547274A1 (en) * 2005-05-20 2006-11-20 Dr. Reddy's Laboratories Limited Stable desloratadine compositions
FR2917620B1 (en) * 2007-06-25 2009-10-23 Aditec Soc Par Actions Simplif PROCESS FOR PREPARING A GRANULATED FORM
CN104706616A (en) * 2008-02-08 2015-06-17 高露洁-棕榄公司 Effervescent compositions
WO2009100267A1 (en) 2008-02-08 2009-08-13 Colgate-Palmolive Company Methods for salt production
PH12012501234A1 (en) 2009-12-18 2017-05-12 Colgate Palmolive Co Methods for production of arginine bicarbonate at low pressure
AU2010332017B2 (en) 2009-12-18 2013-08-15 Colgate-Palmolive Company Method for production of high concentration of arginine bicarbonate solution at high pressure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5225M (en) * 1966-03-15 1967-07-10
IT1196033B (en) * 1984-02-22 1988-11-10 Chiesi Farma Spa COMPOUND WITH ANTI-INFLAMMATORY ACTIVITY OBTAINED BY COMPLEXATION WITH BETA-CYCLODEXTRINE AND RELATED PHARMACEUTICAL FORMULATIONS
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
DE4416769C2 (en) * 1994-05-10 2000-05-25 Pohl Boskamp Gmbh Chem Pharma Medicinal product containing isosorbide-5-mononitrate
IT1293764B1 (en) * 1997-07-23 1999-03-10 Chiesi Farma Spa PHARMACEUTICAL COMPOSITIONS IN THE FORM OF EFFERVESCENT TABLETS CONTAINING AN UNSTABLE ACTIVE IN THE PRESENCE OF WATER

Also Published As

Publication number Publication date
ATE247459T1 (en) 2003-09-15
WO2000032170A1 (en) 2000-06-08
FR2786395A1 (en) 2000-06-02
DE69910610D1 (en) 2003-09-25
EP1135110B1 (en) 2003-08-20
DE69910610T2 (en) 2004-06-17
KR20010093797A (en) 2001-10-29
EP1135110A1 (en) 2001-09-26
JP2002531392A (en) 2002-09-24

Similar Documents

Publication Publication Date Title
WO2003079972A3 (en) Active agent delivery systems and methods for protecting and administering active agents
TR200101814T2 (en) Aqueous reactive filler compositions (II)
HUP0003364A3 (en) Quinoline-indole antimicrobial agents, uses and compositions related thereto
WO2002047671A3 (en) Lactam compound to inhibit beta-amyloid peptide release or synthesis
ZA989560B (en) Compositions containing an Ó 1,2-fucose linkage and uses thereof.
EP0960107A4 (en)
IL113812A0 (en) Copolymer-1, pharmaceutical compositions containing it and its use
ZA979812B (en) Cyanoacrylate compositions comprising an antimicrobial agent.
MXPA02002086A (en) Metalcontaining compositions, preparations and uses.
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
AU9601698A (en) Prepolymer compositions comprising an antimicrobial agent
CA2163706A1 (en) Amino Acid Derivatives of Paclitaxel
IL130102A (en) Aminoguanidines and alkoxyguanidines as protease inhibitors, pharmaceutical compositions containing the same and processes for preparing the same
IL146186A0 (en) Substantially oil-free cyclosporin compositions
WO2002065998A3 (en) Personal care product
NZ333966A (en) Use of 1-nonen-3-one as a flavouring agent
WO2002062304A3 (en) Cosmetic and/or pharmaceutical agents containing an acylated amino acid and a protein condensate
AU1392000A (en) Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses
AU4583599A (en) Di- and tetra-hydroquinoline-indole antimicrobial agents, uses and compositions related thereto
WO2001078682A3 (en) Sustained release drug compositions
EP1097646A3 (en) Modified milk powder composition
MY129632A (en) Wood preservative formulations
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ZA985708B (en) Solubilized sertraline compositions.
EP0784979A3 (en) Obesity protein formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase